30
CARDIOVASCULAR
hamburger

Brazil

The Global Health Economics and Reimbursement Team are experts on establishing reimbursement and demonstrating the economic value of Abbott technologies. We work in every stage of product life - from product development to medical coding and payment. Our goal is to demonstrate to worldwide patients the real value of life improving technologies through economic evidence, medical policy and provider reimbursement.

Ministry of Health

Official Brazil Ministry of Health webpage, containing base information such as health legislation and national healthcare program information.

National Agency for Supplementary Health (ANS)

Brazilian agency responsible for regulating healthcare insurance companies in the private market.

National Health Surveillance Agency (ANVISA)

Brazilian agency which controls all products and services (national and imported) subject to sanitary surveillance, such as medicines, medical devices, health services, food, cosmetics and tobacco derivatives.

National Committee for Technology Incorporation in the National Healthcare Program (CONITEC)

Evaluates and recommends new drugs or medical devices to be added to the National Healthcare Program.

Transparency Portal – Bidding and Hiring

Government website which provides open details on public bidding and hiring, as well as complete federal budgetary information.

Request Information

Please email us for health economics or reimbursement information for our cardiovascular products.

This document and the information contained herein is for general information purposes only and is not intended, and does not constitute, legal, reimbursement, business, clinical, or other advice. Furthermore, it is not intended to and does not constitute a representation or guarantee of reimbursement, payment, or charge, or that reimbursement or other payment will be received. It is not intended to increase or maximize payment by any payer. Similarly, nothing in this document should be viewed as instructions for selecting any particular code, and Abbott does not advocate or warrant the appropriateness of the use of any particular code. The ultimate responsibility for coding and obtaining payment/reimbursement remains with the customer. This includes the responsibility for accuracy and veracity of all coding and claims submitted to third-party payers. In addition, the customer should note that laws, regulations, and coverage policies are complex and are updated frequently, and, therefore, the customer should check with its local carriers or intermediaries often and should consult with legal counsel or a financial, coding, or reimbursement specialist for any questions related to coding, billing, reimbursement or any related issues. This material reproduces information for reference purposes only. It is not provided or authorized for marketing use.

MAT-2012033 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.